Daniel Dunaway, MD
Orthopaedic Surgery · Kettering, OHNPI 1669483152
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $9,500 of the $10,423 with a category attached, or 91.1%. Conformis, Inc. accounts for 94.7% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2019 at $9,092 and has fallen 99.7% since, to $25 in 2025.
Across 16 payments — averaging $651.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Conformis, Inc.$10K
- Stryker$275
- Restor3d, Inc.$201
- Pacira Therapeutics, Inc.$49
- Galderma Laboratories, L.p.$25
Across 7 payments — averaging $21,396 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Conformis, Inc.$150K
What the payments were for
- Speaking & faculty fees$9,50091%
- Travel & lodging$1371%
- Food & beverage$7377%
- Education$490%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Conformis, Inc. | 9 | $9,873 |
| Stryker | 2 | $275 |
| Restor3d, Inc. | 3 | $201 |
| Pacira Therapeutics, Inc. | 1 | $49 |
| Galderma Laboratories, L.p. | 1 | $25 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- iTotal Hip$8,700
- iTotal Identity Cruciate Retaining Knee Replacement System$800
- MAKO$150
- AUGMENT INJECTABLE$125
- iTotal CR$124
- Hip$103
How this compares
$10,423 in reported general payments places this provider in the 70th percentile of 794 orthopaedic surgery providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tramadol Hcl | 372 | $1,164 |
| Oxycodone Hcl | 150 | $1,067 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 46 | $591 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 59 | $555 |
| Methocarbamol | 75 | $460 |
| Celecoxib | 13 | $261 |
| Cefadroxil | 19 | $252 |
| Gabapentin | 37 | $179 |
| Meloxicam | 55 | $137 |
| Cephalexin | 100 | $134 |
| Ibuprofen | 44 | $113 |
| Tizanidine Hcl | 11 | $86 |
| Diazepam | 19 | $57 |
| Clindamycin Hcl | 13 | $11 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Kettering
- Reuben GobezieCleveland$12M
- Gregory BerletWorthington$9.6M
- Wael BarsoumCleveland$8.9M
- Brian CohenChillicothe$8.8M
- Joseph IannottiCleveland$7.1M
- John SontichYoungstown$3.6M
- Anthony MiniaciCleveland$3.1M
- David WelkerMiamisburg$2.8M
- Kenneth GreeneCleveland$2.6M
- Mark FroimsonCleveland$2.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.